CBG Producer Willow Biosciences Announces Record 43% Revenue Increase And Strategic Moves Ahead

Willow Biosciences Inc., (OTC:CANSF) a frontrunner in biotech innovations for sustainable ingredient production, reported its financial and operational results Tuesday morning for the fourth quarter a

BenzingaApr 2 10:02 ET

Willow Biosciences GAAP EPS of -C$0.10, Revenue of C$1.17M

Seeking AlphaMar 29 09:10 ET

Press Release: WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF

WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF PR Newswire SUNNYVALE, Calif., March 28, 2024 Completed the reorganization of the

Dow JonesMar 28 19:30 ET

WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS

Yahoo FinanceJan 16 07:00 ET

Company Exploring CBG Production Signals New Era Of Commercial Success In Synthetic Biology

Biotech company Willow Biosciences Inc. (TSX:WLLW) (OTCQB:CANSF) generated nearly $1.3 million in revenues in 2023, increasing approximately 60% over the period.Dr. Chris Savile, president and CEO of

BenzingaJan 10 14:38 ET

Stocks in Play: Willow Biosciences Inc.

Baystreet.caJan 10 10:00 ET